03:38 PM EST, 11/20/2025 (MT Newswires) -- Health care stocks declined late Thursday afternoon with the NYSE Health Care Index and the Health Care Select Sector SPDR Fund (XLV) each falling 0.3%.

The iShares Biotechnology ETF (IBB) dropped 0.3%.

In corporate news, Jaguar Health's ( JAGX ) subsidiary Napo Pharmaceuticals submitted an amended protocol to the US Food and Drug Administration for its placebo-controlled clinical trial of crofelemer in pediatric patients with microvillus inclusion disease. Jaguar shares fell 8.2%.